This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
Seit Kurzem ist der Interleukin (IL)-17A-Inhibitor Secukinumab zur Behandlung der Hidradenitis suppurativa (HS), auch bekannt als Acne inversa (AI), zugelassen1. Grundlage für die...
Primary immune thrombocytopenia (ITP) is a well-recognized autoimmune bleeding disorder characterized by isolated thrombocytopenia.1–3 Defective production or increased destruction of platelets4...
Highlights from a symposium sponsored by Sanofi and Regeneron Pharmaceuticals held during the 2023 American Academy of Dermatology annual meeting Mark Greener...
Up to 30% of patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2–) high-risk early breast cancer (EBC) will experience distant disease recurrence,...
Expert discussion With Dr Niara Oliveira, Mater Hospital Brisbane And Dr David Pook, Monash Cancer Centre...
In the early days of the COVID-19 pandemic, researchers, drug developers and healthcare providers raced against the clock to find solutions to slow the spread of SARS-CoV-2 and successfully treat the...
Spinal muscular atrophy (SMA) is a rare hereditary neuromuscular disease characterised by progressive deterioration in motor neuron function leading to increasing skeletal muscle weakness and...
Key Points Impaired proximal renal tubular phosphate reabsorption due to the under-expression of sodium-phosphate cotransporters is the fundamental physiologic defect in XLH. Loss of function of...
Adult patients with acute lymphoblastic leukaemia (ALL) have a poorer prognosis in terms of cure rate, compared to the paediatric ALL population.1, 2 While adults achieve relatively high initial...
Onychomycosis is a fungal infection of the nail plate/bed.1 It is one of the most frequent nail disorders in adults and accounts for 15%-40% of all nail diseases.2 The risk factors for onychomycosis...